moxifloxacin + prednisolone

Moxifloxacin + prednisolone is a fixed-dose combination ophthalmic medication used primarily to treat bacterial eye infections and associated inflammation. Moxifloxacin is a fluoroquinolone antibiotic that acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. This results in the death of susceptible bacteria[1][6][8]. Prednisolone is a synthetic corticosteroid that reduces inflammation by suppressing the immune response and blocking the production of inflammatory mediators such as prostaglandins[1][2]. The combination provides both antibacterial action (from moxifloxacin) and anti-inflammatory effects (from prednisolone), making it effective for treating ocular infections with significant inflammatory components[1][2].

Brand names

MoxipredPredmoxMoxifax POccumox PRaymoxi-P4 Quin PDMO 4 PDNMO4 PDNMO-4 PDNMlobe-PDMoxifur P

Other names

moxifloxacin + prednisolone